» Articles » PMID: 37279066

P2Y2 Receptor Decreases Blood Pressure by Inhibiting ENaC

Overview
Journal JCI Insight
Date 2023 Jun 6
PMID 37279066
Authors
Affiliations
Soon will be listed here.
Abstract

Stimulating the Gq-coupled P2Y2 receptor (P2ry2) lowers blood pressure. Global knockout of P2ry2 increases blood pressure. Vascular and renal mechanisms are believed to participate in P2ry2 effects on blood pressure. To isolate the role of the kidneys in P2ry2 effects on blood pressure and to reveal the molecular and cellular mechanisms of this action, we test here the necessity of the P2ry2 and the sufficiency of Gq-dependent signaling in renal principal cells to the regulation of the epithelial Na+ channel (ENaC), sodium excretion, and blood pressure. Activating P2ry2 in littermate controls but not principal cell-specific P2ry2-knockout mice decreased the activity of ENaC in renal tubules. Moreover, deletion of P2ry2 in principal cells abolished increases in sodium excretion in response to stimulation of P2ry2 and compromised the normal ability to excrete a sodium load. Consequently, principal cell-specific knockout of P2ry2 prevented decreases in blood pressure in response to P2ry2 stimulation in the deoxycorticosterone acetate-salt (DOCA-salt) model of hypertension. In wild-type littermate controls, such stimulation decreased blood pressure in this model of hypertension by promoting a natriuresis. Pharmacogenetic activation of Gq exclusively in principal cells using targeted expression of Gq-designer receptors exclusively activated by designer drugs and clozapine N-oxide decreased the activity of ENaC in renal tubules, promoting a natriuresis that lowered elevated blood pressure in the DOCA-salt model of hypertension. These findings demonstrate that the kidneys play a major role in decreasing blood pressure in response to P2ry2 activation and that inhibition of ENaC activity in response to P2ry2-mediated Gq signaling lowered blood pressure by increasing renal sodium excretion.

Citing Articles

Purinergic Receptor Antagonists: A Complementary Treatment for Hypertension.

Bautista-Perez R, Franco M Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204165 PMC: 11357398. DOI: 10.3390/ph17081060.

References
1.
Vallon V, Stockand J, Rieg T . P2Y receptors and kidney function. Wiley Interdiscip Rev Membr Transp Signal. 2012; 1(6):731-742. PMC: 3490424. DOI: 10.1002/wmts.61. View

2.
Rieg T, Gerasimova M, Boyer J, Insel P, Vallon V . P2Y₂ receptor activation decreases blood pressure and increases renal Na⁺ excretion. Am J Physiol Regul Integr Comp Physiol. 2011; 301(2):R510-8. PMC: 3154711. DOI: 10.1152/ajpregu.00148.2011. View

3.
Hille B, Dickson E, Kruse M, Vivas O, Suh B . Phosphoinositides regulate ion channels. Biochim Biophys Acta. 2014; 1851(6):844-56. PMC: 4364932. DOI: 10.1016/j.bbalip.2014.09.010. View

4.
Mendis S, Davis S, Norrving B . Organizational update: the world health organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease. Stroke. 2015; 46(5):e121-2. DOI: 10.1161/STROKEAHA.115.008097. View

5.
Canessa C, Schild L, Buell G, Thorens B, Gautschi I, Horisberger J . Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits. Nature. 1994; 367(6462):463-7. DOI: 10.1038/367463a0. View